Navigation Links
Diabetes, Growth Disorders Drive Sales of Pediatric Hormone Drugs
Date:2/6/2008

NEW YORK, Feb. 6 /PRNewswire/ -- Prescription pediatric drugs represent an enormous market, with manufacturer sales totaling $36.9 billion in 2006. Though overall annual growth is forecast at a modest 3.2%, reaching $43 billion by 2011, the hormone drug segment, with a market share of 11.7%, is expected to achieve the highest growth rate of 8.3% during the same time period, according to Kalorama Information's new report The World Market for Pediatric Drugs.

The high growth rate of the prescription hormone drug segment in the pediatric population, both domestic and worldwide, can be attributed to an increase in the incidence of diabetes, thyroid conditions, and growth disorders, as well as improved screening procedures, better products, availability, effectiveness, education and delivery techniques suitable for children. Within the hormone segment, the highest growth rates are for antidiabetic agents and growth hormone drugs, at 9.1% and 14.4% respectively from 2004 to 2006 and estimated at 5.4% and 10.8% between 2006 and 2011.

"While the focus of most healthcare watchers has been the aging of the world population, one must not forget that children number nearly 2.5 billion, or 40% of the humans on the planet," according to Bruce Carlson, publisher of Kalorama Information. "Developers are starting to see that there is a large unmet need in pediatrics, especially in the hormone category."

Kalorama Information's report The World Market for Pediatric Drugs covers anti-infectives, cancer therapies, and drugs for allergy, respiratory, cardiovascular, central nervous system, gastrointestinal and hormone treatments. Each segment details products, market estimates, forecasts through 2011 and competitive analyses of leading providers. Extensive tables of products in research and development and in-depth discussions of current and future issues and trends are also included, with additional insight from more than 100 interviews with key industry experts. The report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Pediatric-Drugs-Worldwide-1399511/.

About Kalorama Information

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.


'/>"/>
SOURCE Kalorama Information
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. With Obesity, Diabetes, and Cardiovascular Disease on the Rise, Physicians Need More Comprehensive Guidelines
2. Health Secretary Promotes Awareness of Diabetes, Urges Healthy Habits
3. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
4. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
5. Greenway Medical Technologies Continues Record Setting Growth
6. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
7. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
8. Sorafenib Slows Growth of Some Leukemias
9. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
10. P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
11. Fi-Med Management, Inc. Acquires California and Utah-based Mediplete, Looks Ahead to Another Year of Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... Miro is the ultimate smart media center that offers a fascinating home ... and much more apps for user exploration. Its innovative acoustic design with premium speakers ... 720 provides crisp images with remarkable clarity and color. The WiFi connection enables its ...
(Date:2/27/2017)... ... 27, 2017 , ... Texas based retail electric company Discount ... RCE (Residential Customer Equivalent) count exceeds 150,000. , Discount Power was ... and 2,250 RCEs at the time of acquisition. In the three years since ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley ... to announce a new informational post on robotic hair transplantation. San Francisco residents ... hair transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can ...
(Date:2/27/2017)... ... , ... New Jersey ranks among the top five states in the entire ... for advanced services is growing. , Project WE vs C is a focused ... their non-profit partners in their fight against cancer and in support of their shared ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design Awards ... of International Social Design Awards. , The 7th A' Social Design Award ... and Institutions worldwide with realized projects and conceptual works. , The first phase ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017 Halyard Health, Inc. (NYSE: ... and provided its 2017 outlook and related key planning assumptions. ... $410 million, a 2 percent increase compared to the prior ... 2016 was $10 million compared to net income of $15 ... net income was $24 million compared to adjusted net income ...
(Date:2/27/2017)... , Feb. 27, 2017 Mederi Therapeutics ... 28 studies, representing 2468 patients who received  Stretta ... study entitled, " Systematic Review and Meta-Analysis of ... Radiofrequency for Treatment of Gastroesophageal Reflux Disease ", was ... Ronnie Fass , MD, head of the ...
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
Breaking Medicine Technology: